No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy

Ähnliche Einträge

• Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes and tumor location
  von: Labadie, Julia D., et al.
  Veröffentlicht: (2020)
• Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany
  Veröffentlicht: (2007)
• Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
  von: Wunderle, Marius Thorsten, et al.
  Veröffentlicht: (2019)
• Hormones and cancer risk: oral contraceptive use and cancers of the endometrium and breast, and serum sex steroids and breast cancer risk in postmenopausal hormone therapy users
  von: Burchardt, Norah Ana
  Veröffentlicht: (2021)
• Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
  von: Tian, Yu, et al.
  Veröffentlicht: (2024)